AI
VC

Alexandria Venture Investments

United Statesare.com

Alexandria Venture Investments has 25 investments tracked across various sectors and stages. This venture capital firm focuses on multiple sectors and invests in companies at various stages. Monitor Alexandria Venture Investments' activity and portfolio.

61
Investments Tracked

About Alexandria Venture Investments

Operating out of the United States, Alexandria Venture Investments is a venture capital firm. Our dataset covers 61 investments involving Alexandria Venture Investments.

Recorded deals span Healthcare & Life Sciences; Software & Developer Tools; Consumer, Lifestyle & Services and Biotechnology. Coverage extends to 8 sectors in total. Participation spans Series A, Series B and Series C+ rounds.

Focuses on innovative ventures in healthcare and life sciences. Invests in companies developing novel therapies, diagnostics, and technologies to improve human health.

Investment Focus

Stage Focus
series-aseries-bseries-c-plus
Sectors
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & Servicesbiotechnologydrug discoverybiotechGenomics & Molecular Biologyoncology

Investment Thesis

Focuses on innovative ventures in healthcare and life sciences. Invests in companies developing novel therapies, diagnostics, and technologies to improve human health.

Alexandria Venture Investments Portfolio Companies

24 of 60 tracked holdings.

miReculeUnited StatesSynthegoUnited StatesAxonisUnited StatesNextVivoUnited StatesAIRNAUnited StatesAbility biologicsUnited StatesQurAlisUnited States
Soteria BiotherapeuticsUnited States
Redpin TherapeuticsUnited States
Abacus BioscienceUnited States
TARA BiosystemsUnited States
Veralox TherapeuticsUnited States
NItrome BiosciencesUnited States
Archon BiosciencesUnited States
Silverback TherapeuticsUnited States
Invaio SciencesUnited States
Mirador TherapeuticsUnited States
MOMA TherapeuticsUnited States
antiva biosciencesUnited StatesParatus SciencesUnited States
CREATE MedicinesUnited States
Portal InnovationsUnited States
Remix TherapeuticsUnited States
Arrakis TherapeuticsUnited States
Portfolio outcomes
22 active1 stalled1 defunct

Team

Joel S. MarcusDean A. ShigenagaJames P. BurnsJennifer HartiganHallie KuhnArmel Le Cléac'hMark D. McLellanDaniel D'Agostino

Explore Alexandria Venture Investments's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Software & Developer Tools